BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10207023)

  • 1. Modulation of E2F complexes during G0 to S phase transition in human primary B-lymphocytes.
    van der Sman J; Thomas NS; Lam EW
    J Biol Chem; 1999 Apr; 274(17):12009-16. PubMed ID: 10207023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of E2F activity in primary mouse B cells following stimulation via surface IgM and CD40 receptors.
    Lam EW; Glassford J; van der Sman J; Banerji L; Pizzey AR; Shaun N; Thomas B; Klaus GG
    Eur J Immunol; 1999 Oct; 29(10):3380-9. PubMed ID: 10540350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon.
    Thomas NS; Pizzey AR; Tiwari S; Williams CD; Yang J
    J Biol Chem; 1998 Sep; 273(37):23659-67. PubMed ID: 9726970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
    Mann DJ; Jones NC
    Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes.
    Puri PL; Balsano C; Burgio VL; Chirillo P; Natoli G; Ricci L; Mattei E; Graessmann A; Levrero M
    Oncogene; 1997 Mar; 14(10):1171-84. PubMed ID: 9121766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization.
    Müller H; Moroni MC; Vigo E; Petersen BO; Bartek J; Helin K
    Mol Cell Biol; 1997 Sep; 17(9):5508-20. PubMed ID: 9271426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The subcellular localization of E2F-4 is cell-cycle dependent.
    Lindeman GJ; Gaubatz S; Livingston DM; Ginsberg D
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5095-100. PubMed ID: 9144196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.
    Le Cam L; Polanowska J; Fabbrizio E; Olivier M; Philips A; Ng Eaton E; Classon M; Geng Y; Sardet C
    EMBO J; 1999 Apr; 18(7):1878-90. PubMed ID: 10202151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F proteins are posttranslationally modified concomitantly with a reduction in nuclear binding activity in cells infected with herpes simplex virus 1.
    Advani SJ; Weichselbaum RR; Roizman B
    J Virol; 2000 Sep; 74(17):7842-50. PubMed ID: 10933691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
    Halaban R; Cheng E; Smicun Y; Germino J
    J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
    Hu X; Cress WD; Zhong Q; Zuckerman KS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G1/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter.
    Dou QP; Zhao S; Levin AH; Wang J; Helin K; Pardee AB
    J Biol Chem; 1994 Jan; 269(2):1306-13. PubMed ID: 8288595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F-1 and a cyclin-like DNA repair enzyme, uracil-DNA glycosylase, provide evidence for an autoregulatory mechanism for transcription.
    Walsh MJ; Shue G; Spidoni K; Kapoor A
    J Biol Chem; 1995 Mar; 270(10):5289-98. PubMed ID: 7534293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase.
    Ferreira R; Magnaghi-Jaulin L; Robin P; Harel-Bellan A; Trouche D
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10493-8. PubMed ID: 9724731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional matrix suppresses E2F-controlled gene expression in glomerular mesangial cells.
    Tsuboi N; Yoshida H; Kawamura T; Furukawa Y; Hosoya T; Yamada H
    Kidney Int; 2000 Apr; 57(4):1581-9. PubMed ID: 10760093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431.
    Ahmad N; Gupta S; Mukhtar H
    Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H; Iavarone A; Reeves SA
    Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
    Magae J; Illenye S; Chang YC; Mitsui Y; Heintz NH
    Oncogene; 1999 Jan; 18(3):593-605. PubMed ID: 9989809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
    Hsiao KM; McMahon SL; Farnham PJ
    Genes Dev; 1994 Jul; 8(13):1526-37. PubMed ID: 7958837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.